Last reviewed · How we verify

NCT03811444

Simulated Clinical Use Testing On Safety Lancets (Test B)

Completed NA Last updated 22 January 2019
What this trial tests

NA trial testing Haemolance Plus safety lancet in Needle Stick in 30 participants. Completed in 13 December 2018.

Timeline
30 November 2018
Primary endpoint
13 December 2018
13 December 2018

Quick facts

Lead sponsorHTL-Strefa S.A.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment30
Start date30 November 2018
Primary completion13 December 2018
Estimated completion13 December 2018
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

HTL-Strefa S.A.

Who can join

18 and older, any sex, with Needle Stick. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A simulated clinical use testing on the HTL-Strefa's safety lancets

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other HTL-Strefa S.A. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03811444.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing